Tech Company Financing Transactions
Rocket Pharmaceuticals Funding Round
Rocket Pharmaceuticals, operating out of Cranbury, scored $150 million from Hercules Capital.
Transaction Overview
Company Name
Announced On
10/6/2026
Transaction Type
Debt
Amount
$150,000,000
Round
Undisclosed
Investors
Hercules Capital (R. Bryan Jadot)
Proceeds Purpose
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9 Cedarbrook Drive
Cranbury, NJ 08512
USA
Cranbury, NJ 08512
USA
Phone
Website
Email Address
Overview
Our mission is to seek gene therapy cures for patients with devastating rare diseases through the most innovative science and platforms to fulfill the promise of gene therapy for the betterment of our industry, science and humanity. Our vision is to free every patient and the world from rare genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Peter Fong
Chief Executive Officer
Gaurav Shah
Chief Medical Officer
Syed Rizvi
Chief Operating Officer
Chris Stevens
Chief Scientific Officer
Jonathan Schwartz
VP - Bus. Development
Sarbani Chaudhuri
VP - General Counsel
Martin Wilson
VP - Regulatory Affairs
Meg Dodge
Browse more venture capital transactions:
Prev: 10/6/2026: Cleavr venture capital transaction
Next: 10/6/2026: It'sugar venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs